Climb Bio, Inc. — Director's Dealing 2025

Jun 23, 2025

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Climb Bio, Inc. (CLYM)
CIK: 0001768446
Period of Report: 2025-06-17

Reporting Person: Wilson Perrin Megan (N/A)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$1.58	2035-02-09	Common Stock (600000)		Direct

Footnotes

F1: The option was granted on February 10, 2025 (the "Grant Date"). The shares underlying the option are scheduled to vest with respect to 25% of the shares on the first anniversary of the Grant Date and the remainder are scheduled to vest in 36 equal monthly installments through February 10, 2029, subject to the Reporting Person's continued service.